As the proposed Anthem-Cigna merger and the Aetna-Humana deal enter a period seeking antitrust clearance and government scrutiny, consolidating health insurers are facing a chorus of criticism from medical-care providers and consumer advocates. And it’s something investors should keep an eye on amid the historic bull run of health-plan stocks.